Nasdaq GlobeNewswire

OLYMPUS LABS LAUNCHES PRE-ICO BRINGING A NEW FINANCIAL ECOSYSTEM TO THE BLOCKCHAIN WORLD

Del

New York, NY, Nov. 29, 2017 (GLOBE NEWSWIRE) -- As blockchain and cryptocurrency companies continue to raise millions of dollars in funding, there's an urgent need in the market for companies and investors to be able to better manage its cryptocurrency assets with hedging products and tools. Olympus Labs believes that by offering financial tools and protocol, crypto- based companies and investors will be able to have more control by protecting their downside risk in an otherwise extremely volatile market.

"Olympus Labs is an integrator of cryptocurrency-based financial products (e.g., indices, ETFs, options, futures, etc.). Olympus, third-party financial product developers, and Fintech applications build the products which include but are not limited to exchanges, market analytics tools, payment services, etc. (e.g., Kyber, Shapeshift, Sentiment)," explains Kai Chen, CEO of Olympus Labs.

On November 27, 2017 due to the high demand from outside investors Olympus Labs opened its doors for its Pre-ICO token sale.

The Olympus product is viable and has huge long-term potential. As for competition, it fills an evidently empty space in the cryptocurrency market, practically guaranteeing that Olympus' offerings will be used-and that this usage will generate profits. Olympus's mission is to "define the protocol for crypto-based derivatives," and it seems clear that these products will help mature the market beyond the current spot market.

The first of Olympus's products will allow one to borrow and lend bitcoin. Cryptocurrency index funds will be the second Olympus product to hit the market. These index funds will allow investors to buy into multiple cryptocurrencies at once, with profits moving with the market as a whole instead of with individual spot cryptocurrencies. Through customizable fintech-focused smart contracts, exchanges will be able to quickly and easily make their own indices which track the overall trend of cryptocurrencies traded on that exchange.

To Participate in the Pre-ICO

The Olympus Labs Token Sale started at 8 pm (GMT+8/UTC 12pm), 27 November 2017, and ends at 8pm (GMT+8/UTC 12 pm), 3 December 2017.Olympus Presale terms: Investors contributing more than 100 ETH, will get 10% bonus (1 ETH = 677 Olympus tokens). This will take place after ICO, and those who passed the KYC process, will be issued MOT, the rest who failed in KYC, will be refunded with ETH. For additional information and terms of the sale please visit the Olympus Labs website.

During the registration period (27 November 2017 to 3 December 2017), please visithttps://kyc.olympuslabs.io/.

Note: Information regarding the token sale will ONLY be disseminated on our official communication channels: our official website and our official telegram group.

About OLYMPUS LABS

Olympus is led by a cohesive team with extensive expertise in both the traditional financial markets and blockchain technology. Olympus Founder and CEO Kai Chen started his career on Wall Street with Morgan Stanley, and he later went on to work for McKinsey and PIMCO. Our development team includes Google's former development community lead for China. On the business side, we have Danielle Sabrina, a highly sought-after marketing expert and veteran of several successful ICOs, and has helped her clients achieve prestigious awards such as Inc 500, Forbes Next Billion Dollar Startup, Entrepreneur 360 among other top level recognition. Danielle's work has also been featured in Huffington Post and Entrepreneur. Olympus also has a strong advising board made up of former executives at Morgan Stanley and McKinsey.

OLYMPUS LABS Social Media

For more information about Olympus Labs and the launch of the pre-ICO, please visit https://olympuslabs.io/web; on Twitter @olympuslabsbc and Telegram at https://t.me/olympuslabs.

###

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a88937da-05db-437e-92f0-07cc02b4dd8f

Danielle Sabrina
Olympus Labs
pr@oympuslabs.io

Sharde' Brown
What Vibes Your Tribe
press@wvytmedia.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: OLYMPUS LABS via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

GlobeNewswire Test Release16.6.2018 07:00Pressemelding

LOS ANGELES, June 15, 2018 (GLOBE NEWSWIRE) -- This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING – -END- CONTACT: Karen Yu Director, GlobeNewswire Product Management Direct: +1 310 258 6917 Mobile: +1 626 389 7427 or Magali Rolandez Senior Manager, Media Relations/Content Distribution Europe Direct: +44 (0) 203 753 2215 Mobile: +44 (0) 7785 619 539

INVNT/IP: US Responds to Nation-sponsored Crown-jewel Intellectual Property Theft15.6.2018 23:34Pressemelding

US Announcement of Large-Scale Tariffs in Response to Chinese Crown-Jewel Intellectual Property Theft Lauded by IP Protection Consortium INVNT/IP SEATTLE, June 15, 2018 (GLOBE NEWSWIRE) -- The Trump administration today announced 25% tariffs on $50 billion in Chinese goods, representing the first time the United States government has marked sectors in US-China trade for retaliation as a response to theft of crown-jewel intellectual property. In a public statement, President Trump announced that the measures were targeted toward goods that "contain industrially significant technologies." US Trade Representative Robert Lighthizer applauded the move on Fox News, noting, "It's thorough. It's moderate. It's appropriate." In a further explanation of the move, he added, "What I want to do is make sure that we protect our technology here at home, that we stop cybertheft and forced technology transfer, and ultimately, remember: 'China 2025' is a $300 billion subsidy program. The United States h

Brookfield Asset Management Announces Results of Annual and Special Meeting of Shareholders15.6.2018 22:30Pressemelding

BROOKFIELD, NEWS, June 15, 2018 (GLOBE NEWSWIRE) -- Brookfield Asset Management Inc. (TSX:BAM.A) (NYSE:BAM) (Euronext:BAMA) today announced that at the company's annual and special meeting of shareholders held earlier today in Toronto, approximately 92% of Class A Limited Voting Shares ("Class A Shares") voted in favour of an advisory vote approving the company's approach to executive compensation. In addition, at the meeting all eight nominees proposed for election to the board of directors by holders of Class A Shares and all eight nominees proposed for election to the board of directors by the holder of Class B Limited Voting Shares ("Class B Shares") were elected. Detailed results of the vote for the election of directors are set out below. Management received the following proxies from holders of Class A Shares in regard to the election of the eight directors nominated by this shareholder class: Director Nominee Votes For % Votes Withheld % M. Elyse Allan 620,669,437 99.53 2,921,9

NEP Completes Acquisition of Telerecord15.6.2018 13:53Pressemelding

FLORENCE, Italy, June 15, 2018 (GLOBE NEWSWIRE) -- Today NEP Group, a leading outsourced technical production partner supporting premier content producers of live sports and entertainment, announced that it has completed its acquisition of Telerecord, an Italy-based provider of outside broadcast solutions. Telerecord, a local industry leader with strong client relationships, covers popular sporting events in Italy and throughout Southern Europe including football, ice hockey and bobsleigh. The deal further diversifies NEP's business and expands its reach in Europe by adding additional local resources and talent. As part of the deal, all Telerecord staff members will join NEP. Telerecord will be rebranded as NEP and will be part of NEP Italy, which is led by Sergio Cecchini, GM of NEP Italy, who joined NEP in May. Telerecord also brings a fleet of several outside broadcast trucks, sprinter vans and motorcycles to the NEP Worldwide Network to serve clients across Europe. "We couldn't be

Fortuna Reports Results of Annual General Meeting15.6.2018 11:00Pressemelding

VANCOUVER, British Columbia, June 15, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE:FSM) (TSX:FVI) hereby announces the voting results at the Company's annual general meeting held on June 14, 2018. A total of 108,538,241 common shares were represented at the meeting, being 68% of the Company's issued and outstanding shares. Shareholders voted in favour of all matters brought before the meeting including the appointment of auditors, the election of management's nominees as directors, and the ratification and approval of the Company's amended Advance Notice Policy. Detailed results of the votes on the election of directors are as follows: Director Votes For Votes Withheld Jorge Ganoza Durant Simon Ridgway Mario Szotlender David Farrell David Laing Alfredo Sillau Kylie Dickson 74,947,635 (97.4%) 63,448,600 (82.5%) 70,831,225 (92.1%) 74,816,864 (97.3%) 73,597,731 (95.7%) 75,716,342 (98.4%) 76,476,115 (99.4%) 1,930,230 (2.5%) 13,429,266 (17.4%) 6,046,640 (7.9%) 2,061,001 (2.7%) 3

ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 201815.6.2018 07:31Pressemelding

LYON, France, June 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will present preclinical data on the enzymatic activity of eryaspase (GRASPA®) for the treatment of relapsed acute lymphoblastic leukemia (ALL) and results of its Phase 2b clinical trial evaluating eryaspase (GRASPA®) for the treatment of acute myeloid leukemia (AML) at the European Hematology Association (EHA) Congress, being held June 14-17, 2018 in Stockholm, Sweden. The preclinical eryaspase data will be presented during Poster Session I by Dr. Karine Aguera, ERYTECH's R&D Project Leader. Poster Session: Preclinical Demonstration of Intracellular Activity of Asparaginase Encapsulated in Red Blood Cells Both in the Absence and in the Presence of Neutralizing Anti-Asparaginase Antibodies Abstract #: PF160 Lead Author: Karine A

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom